Currently, Impact BioMedical Inc [IBO] is trading at $2.08, up 292.45%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The IBO shares have gain 210.36% over the last week, with a monthly amount glided 4.00%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
This stock has fluctuated between a low of $0.51 and a high of $3.25 over the last 52 weeks. Impact BioMedical Inc [AMEX: IBO] shares were valued at $2.08 at the most recent close of the market.
Analyzing the IBO fundamentals
Gross Profit Margin for this corporation currently stands at 1.0% with Operating Profit Margin at 0.46%, Pretax Profit Margin comes in at -9.8%, and Net Profit Margin reading is -9.8%. To continue investigating profitability, this company’s Return on Assets is posted at -1.66, Equity is -3.05 and Total Capital is 0.09. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.44.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 24.84 points at the first support level, and at 24.84 for the second support level. However, for the 1st resistance point, the stock is sitting at 24.84, and for the 2nd resistance point, it is at 24.84.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Impact BioMedical Inc [AMEX:IBO] is 2.79. Also, the Quick Ratio is 2.79, while the Cash Ratio stands at 1.14.
Transactions by insiders
Recent insider trading involved Heuszel Frank D, Chief Executive Officer, that happened on Dec 05 ’24 when 500.0 shares were purchased. Chief Executive Officer, Heuszel Frank D completed a deal on Nov 27 ’24 to buy 500.0 shares. Meanwhile, Chief Executive Officer Heuszel Frank D bought 1050.0 shares on Nov 26 ’24.
